Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Research

Impact of Statewide Program To Promote Appropriate Antimicrobial Drug Use

Edward A. Belongia*Comments to Author , Mary Jo Knobloch*, Burney A. Kieke*, Jeffrey P. Davis‡, Carolyn Janette‡1, and Richard E. Besser§
Author affiliations: *Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Wisconsin Division of Public Health, Madison, Wisconsin, USA; ‡Wisconsin Medical Society, Madison, Wisconsin, USA; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 4

Changes in antimicrobial drug prescribing by specialty and state, 1998–2003*

Specialty Wisconsin prescribing rate
 Minnesota prescribing rate
1998 2003 % reduction 1998 2003 % reduction p value†
Family practice 810 631 22 843 685 19 0.11
Internal medicine 540 447 17 366 329 10 0.03
Pediatrics 1,126 891 21 1,068 751 30 0.006
Emergency medicine 519 451 13 306 303 1 0.25

*The annual antimicrobial drug prescribing rate was calculated by dividing the number of new filled prescriptions by the number of prescribers in each specialty.
†p value for comparison of reduction in Wisconsin vs. Minnesota.

Main Article

1Carolyn Janette is currently affiliated with Meriter Hospital, Madison, Wisconsin, USA.

The footnote "1 " is not cited in the text. Please add an in-text citation or delete the footnote.

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external